2019
DOI: 10.5334/tohm.491
|View full text |Cite
|
Sign up to set email alerts
|

DaT Scan “Abnormality” in Hyperglycemic-Hemichorea

Abstract: BackgroundHyperglycemic-hemichorea is a well-established clinical entity which leads to signal changes on brain MRI. We are reporting a case of hyperglycemic-hemichorea where the DaT scan showed reduced uptake bilaterally.Case ReportA 57-year-old female was seen in the clinic for hemichorea due to hyperglycemia. Her brain magnetic resonance imaging (MRI) showed increased T1 signal intensity in bilateral lenticular nuclei and the DaT scan showed reduced uptake on both sides.DiscussionThis case highlights the im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 15 publications
1
6
0
Order By: Relevance
“…Dopamine transporter (DaT) SPECT imaging in two case reports demonstrated decreased uptake contralateral to the affected side [ 49 50 ]. In both cases the patients did not demonstrate clinical parkinsonism and no follow up was reoirted to determine whether these patients went on to develop PD or if the DaT changes remained with resolution of their chorea [ 49 50 ].…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Dopamine transporter (DaT) SPECT imaging in two case reports demonstrated decreased uptake contralateral to the affected side [ 49 50 ]. In both cases the patients did not demonstrate clinical parkinsonism and no follow up was reoirted to determine whether these patients went on to develop PD or if the DaT changes remained with resolution of their chorea [ 49 50 ].…”
Section: Resultsmentioning
confidence: 99%
“…Dopamine transporter (DaT) SPECT imaging in two case reports demonstrated decreased uptake contralateral to the affected side [ 49 50 ]. In both cases the patients did not demonstrate clinical parkinsonism and no follow up was reoirted to determine whether these patients went on to develop PD or if the DaT changes remained with resolution of their chorea [ 49 50 ]. One case speculated that the finding was clinically significant and represented true decreased presynaptic dopaminergic uptake [ 49 ] while the second suggested that the finding was secondary to structural changes in the basal ganglia related to the T1 changes on MRI [ 50 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Some of the clinical-radiological discrepancies may be resolved with the help of SPECT study [14,15]. However, apparently superior and sophisticated investigations like DOI: 10.1159/000524936 dopamine transporter (DAT) (to detect dopaminergic integrity) and positron emission tomography scan (to detect a failure in metabolism in different substrates of basal ganglia) may not always be devoid of drawbacks [16,17]. The lesions involving the basal ganglia can lead to either a hypokinetic or hyperkinetic movement disorder depending on the involved pathway.…”
Section: Pathophysiological Basis Of Ds and Its Clinical And Neurorad...mentioning
confidence: 99%
“…The lesions involving the basal ganglia can lead to either a hypokinetic or hyperkinetic movement disorder depending on the involved pathway. Hence, a patient with a structural abnormality in the basal ganglia can have a hyperkinetic movement disorder despite an abnormal DAT scan [16].…”
Section: Pathophysiological Basis Of Ds and Its Clinical And Neurorad...mentioning
confidence: 99%